Media Inquiries
For inquiries, please contact mediarelations@vyriad.com
September 28, 2026
Separating targeting from vector engineering could help reduce barriers to scalable in vivo CAR-T development while preserving existing manufacturing workflows. The article begins on page 45 of the September 2026 issue of European Pharmaceutical Review.
For inquiries, please contact mediarelations@vyriad.com